COVID-19 Update | September 25, 2020

COVID-19 News

COVID-19 Update | September 25, 2020

September 25, 2020

The California Biotechnology Foundation is committed to keeping you up to date about COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of September 25, 2020. Notable advancements include:

  • Johnson & Johnson has entered the final stage of testing for its experimental COVID-19 vaccine, enrolling 60,000 volunteers in a landmark study.
  • The U.S. Food and Drug Administration issued an emergency use authorization for the first antibody point-of-care test for COVID-19.
  • Lumen Bioscience was awarded a $4 million grant by the U.S. Army Medical Research and Development Command to develop a biologic drug to treat gastrointestinal (GI) infection in COVID-19 patients.

Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.

Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new

If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or [email protected].